|
RFFL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.163240E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.172580E-01 |
| Normal-vs-Stage2 |
8.287200E-01 |
| Normal-vs-Stage3 |
3.604600E-01 |
| Normal-vs-Stage4 |
1.082420E-01 |
| Stage1-vs-Stage2 |
3.569600E-01 |
| Stage1-vs-Stage3 |
6.475400E-01 |
| Stage1-vs-Stage4 |
5.568400E-01 |
| Stage2-vs-Stage3 |
6.165400E-01 |
| Stage2-vs-Stage4 |
2.594400E-01 |
| Stage3-vs-Stage4 |
3.917000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.554200E-02 |
| Normal-vs-AfricanAmerican |
5.901200E-01 |
| Normal-vs-Asian |
1.024610E-01 |
| Caucasian-vs-AfricanAmerican |
6.947800E-02 |
| Caucasian-vs-Asian |
4.241700E-02 |
| AfricanAmerican-vs-Asian |
1.819780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.149400E-01 |
| Normal-vs-Female |
8.164600E-03 |
| Male-vs-Female |
9.120900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.884410E-01 |
| Normal-vs-Age(41-60Yrs) |
6.895800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.969580E-01 |
| Normal-vs-Age(81-100Yrs) |
3.298200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.547600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.227800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.046980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.454400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.562200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.903800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.089600E-01 |
| Normal-vs-Grade 2 |
3.028800E-01 |
| Normal-vs-Grade 3 |
1.458420E-01 |
| Normal-vs-Grade 4 |
5.972300E-02 |
| Grade 1-vs-Grade 2 |
5.347200E-01 |
| Grade 1-vs-Grade 3 |
6.575000E-01 |
| Grade 1-vs-Grade 4 |
9.951800E-01 |
| Grade 2-vs-Grade 3 |
6.063800E-01 |
| Grade 2-vs-Grade 4 |
2.015400E-01 |
| Grade 3-vs-Grade 4 |
3.662200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.571550E-02 |
| Normal-vs-ccB subtype |
3.408800E-01 |
| ccA subtype-vs-ccB subtype |
1.525850E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.745900E-02 |
| Normal-vs-N1 |
5.192000E-02 |
| N0-vs-N1 |
7.550400E-02 |
|
|
